marches200 millionOSE Immuno joins €200 million venture capital fund

OSE Immuno joins €200 million venture capital fund

French biotech OSE Immuno was selected to join a new €200 million venture capital fund aimed at accelerating innovative therapy development.

Published 11sem1 sourceImportantupdated 4j

Lire en français

≈ 16sSpeed

The fact

The investment reflects investor confidence in the company's breakthrough projects.

Click the link to read an article on the topic:

Boursorama

Explore this topic

France OSE Immuno #biotech #capital-risque #innovation #financement #thérapies

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.

Observed impact

Accélération attendue du développement des thérapies de rupture d'OSE Immuno

Renforcement de la position concurrentielle du groupe dans le secteur de la biotech

FranceWorld map →

Follow topic →

Auto-synthesis from 1 media source · identified on April 29, 2026

← Back to home

The fact

Observed impact

Read more

Immuotherapeutics annonce un événement non précisé sur le forum Boursorama en mai 2026

Merck rachète un fournisseur américain d'équipements de laboratoire pour 9,9 milliards d'euros

OSE Immunotherapeutics secures bridge financing with IRIS

OSE Immuno: valuation disconnected from clinical progress

OSE Immunotherapeutics targets 100 euros with clinical prospects

OSE Immunotherapeutics surges more than twenty percent on announcement